Management of recent-onset diabetes offers osteopathic physicians the opportunity to work with patients to set treatment goals and expectations for this progressive yet manageable disease, as well as intervene early to reduce the risk of diabetesrelated complications. Starting effective therapy early-and intensifying therapy appropriately-to achieve and maintain glycemic goals has been shown to reduce microvascular risks and produce legacy effects that may have macrovascular benefits.
If needed to reach individualized HbA 1c target after ~3 months, proceed to 3-drug combination (order not meant to denote any specific preference):
Metformin + Metformin + Metformin + physicians. However, they must also 
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